(NewsNation) — Researchers at the University of Rochester transferred a longevity gene from naked mole rats to mice, calling it a “groundbreaking endeavor.”
According to the University of Rochester, naked mole rats have long captured the attention of scientists for their lengthy lifespans and resistance to age-related diseases.
The development of your baby’s brain could be influenced by the microbes in their belly, scientists have found.
The trillions of microbes that live inside our guts play essential roles in a range of bodily processes, from digestion to mental health. The gut contains more than 100 million nerve cells—the highest concentration in any part of the body other than the brain. Now, we are also beginning to learn about the roles of these microbes in the earliest stages of our lives.
“The microbiome plays an important role in the early development of several systems, such as the nervous and immune system, as well as providing another layer of protection against pathogens [disease],” Sebastian Hunter, a researcher from the University of British Columbia who led a study on the subject published Wednesday in the scientific journal PLOS One, told Newsweek.
The new tool has the capacity to undertake strand-specific gene editing without any cuts.
Chinese researchers claim to have created a new gene-editing technique called CyDENT that is more effective than Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology.
This is according to a report by the South China Morning Post (SCMP) published on Saturday.
The cutting-edge gene-editing technique CRISPR enables precise DNA changes within an organism’s genome. Its development in the past few years has significantly advanced genetic engineering and biotechnology.
As the Indian healthcare sector increasingly adopts robotic surgery, Dr. Mahendra Bhandari, the CEO of the US-based Vattikuti Foundation and a prominent advocate for robotic surgery, highlights the growing presence of various surgical robots from multiple vendors. He underscores the rising number of trained doctors and the commitment of both government and corporate hospitals to invest in surgical robots across the country.
The Vattikuti Foundation, founded by Indian American entrepreneur and philanthropist Raj Vattikuti, serves communities in Michigan, USA, and India. It initiated the Vattikuti Urology Institute at Henry Ford Health in Detroit, Michigan, in 1997 and has since evolved into an international organisation promoting excellence in robotic surgery through various avenues.
In an exclusive interview Dr. Jayati Dubey, DHN, speaks to Dr. Bhandari on the expanding scope of robotic surgery in India.
Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD
Discount Links:
Oral Microbiome: https://www.bristlehealth.com/?ref=michaellustgarten.
Enter Code: ConquerAging.
At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.
Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING
At-Home Blood Testing (SiPhox Health): https://getquantify.io/mlustgarten.
That’s perfect and from one of the most technological countries. It’s late and I saved it for watching later but I can imagine what is in this video. AI is always useful especially in medicine.
[Skip Intro] 0:22
Learn more about science on NHK WORLD-JAPAN:
https://www3.nhk.or.jp/nhkworld/en/ondemand/category/23/?cid…9-sv303-hp.
More quality content available on NHK WORLD-JAPAN:
https://www3.nhk.or.jp/nhkworld/en/ondemand/video/?cid=wohk-yt-2309-sv303-hp.
The integration of artificial intelligence into healthcare seeks to reduce diagnosis errors while increasing humanity.
The Conboys’ statement on plasma dilution is important:
The pair are quick to add that this isn’t going to have a Benjamin Button effect, and the research “wasn’t geared to make old people young” – even if this idea is being bio-hacked around the world. “It was clear that there were improvements after a couple of procedures,” says Irina. “[But] it’s not really healthy or rejuvenating to drain somebody of 70% of their blood and replace it with something.” She warns people to wait until more research is done.
Still, they believe that in the next five years we will see huge advancements in prolonging life treatments – including taking a pill instead of getting blood, and a “fountain of middle age”. “People will be able to have this high quality, productive life where they are healthy for many more decades,”
A fascinating and often terrifying new podcast delves into the lengths ‘longevity superstars’ will go to make 90 the new 50, from swapping blood with the young to designing the first ‘post-humans’
BARDA is part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.
The NTxscribe platform is a cell-free, continuous flow manufacturing system that reportedly delivers scalable RNA (including mRNA and self-amplifying RNA) materials in a tabletop footprint. This enzymatic process is designed to provide a low cost and rapidly deployable, vertically integrated manufacturing system, according to Jamie Coffin, PhD, CEO of NTx. Through this program, the system is being evaluated for its express development of RNA vaccines and therapeutics for infectious diseases, as well as its capability for distributed biomanufacturing.
“The traditional batch processes for developing vaccines and other biologics are burdensome and cannot be scaled quickly in the event of an emergency,” said Coffin. “Over the course of this project, we will aim to prove that NTxscribe can help BARDA meet its goals toward decentralized and rapidly deployable vaccine manufacturing.”
Artificial intelligence is not the only technology advancing at a rapid pace. Robot surgeons are now the real deal, which will revolutionize surgical procedures and transform patients’ lives.
Posted in biotech/medical, genetics, life extension
Gene therapy for longevity and targeted disease treatment.
Gene therapy has the power to extend healthy longevity and treat a litany of organ-specific conditions.
The eye is one outstanding candidate.
Luxturna received FDA approval in 2017. It targets a rare form of retinal dystrophy caused by RPE65 mutations.
